| abstract |
A tumor antigen peptide specifically recognized by cytotoxic T lymphocytes that damage HLA-A24-restricted cancer cells and DNA encoding the same, the peptide, or DNA encoding the peptide. Provided is a cytotoxic T lymphocyte that damages cancer cells in a restricted manner by HLA-A24, a method for inducing the same, and a cancer vaccine containing these tumor antigen peptides or DNA encoding the same. A tumor antigen peptide, which is a peptide consisting of the amino acid sequence of NYGFQIHTK (SEQ ID NO: 1). [Selection figure] None |